Pacific Genetech

Pacific Genetech is a biotechnology startup founded in 2009, headquartered in the United States, and operating under the slogan "NextGen Vaccine Technologies." The company focuses on developing novel vaccine and adjuvant technologies to address unmet needs in the veterinary and human market sectors. Their core technology, a proprietary platform, is designed for low-cost orally administered recombinant vaccines against bacterial, viral, and parasitic diseases. In 24 August 2022, Pacific Genetech secured a significant $10.00M Venture Round investment from a group of notable investors, including Arkansas Development Finance Authority, Simmons Foods, Whist Subholdings, FHB Ventures, and PT Medion. Pacific Genetech operates within the industries of Agriculture, Biotechnology, Food and Beverage, and Health Care. With their focus on cutting-edge vaccine technologies, the company shows promise in addressing critical health challenges in both human and animal populations, making it an intriguing prospect for potential investors in the biotech sector.